PS Ratio Chart

View PS Ratio for PACS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio Chart
Start Trial

Historical PS Ratio Data

View and export this data back to 2024. Start Trial.
Date Value
September 10, 2026 1.304
September 09, 2026 1.296
September 08, 2026 1.269
September 04, 2026 1.235
September 03, 2026 1.252
September 02, 2026 1.252
September 01, 2026 1.225
August 31, 2026 1.230
August 28, 2026 1.243
August 27, 2026 1.286
August 26, 2026 1.290
August 25, 2026 1.277
August 24, 2026 1.286
August 21, 2026 1.286
August 20, 2026 1.267
August 19, 2026 1.286
August 18, 2026 1.273
August 17, 2026 1.288
August 14, 2026 1.292
August 13, 2026 1.308
August 12, 2026 1.322
August 11, 2026 1.306
August 10, 2026 1.408
August 07, 2026 1.408
August 06, 2026 1.356
Date Value
August 05, 2026 1.327
August 04, 2026 1.302
August 03, 2026 1.293
July 31, 2026 1.337
July 30, 2026 1.366
July 29, 2026 1.351
July 28, 2026 1.365
July 27, 2026 1.368
July 24, 2026 1.362
July 23, 2026 1.303
July 22, 2026 1.310
July 21, 2026 1.324
July 20, 2026 1.300
July 17, 2026 1.341
July 16, 2026 1.326
July 15, 2026 1.308
July 14, 2026 1.306
July 13, 2026 1.258
July 10, 2026 1.256
July 09, 2026 1.274
July 08, 2026 1.280
July 07, 2026 1.268
July 06, 2026 1.308
July 02, 2026 1.293
July 01, 2026 1.288

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Centene Corp. 0.1592
CVS Health Corp. 0.2934
The Cigna Group 0.2638
Humana, Inc. 0.3321
Molina Healthcare, Inc. 0.2314

PS Ratio Related Metrics